TruSpine Technologies Limited

Early Equity has invested, by way of subscription, GBP60,000 in TruSpine Technologies Limited (“TruSpine”) on a pre-new money valuation of GBP15m.

Founded in December 2014, TruSpine secured intellectual property and subsequently developed the Faci-LOK and Cervi-FAS minimally invasive spine stabilisation devices, and the VOSC Catheter atherosclerosis treatment product ‘VOSC Catheter’. This development is on-going and TruSpine is targeting FDA clearance and commercialisation of its first product, the Faci-LOK.